Previous 10 | Next 10 |
– Q3 2020 Total Revenue of $74.3 million – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended Septemb...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2020 financial results after market close on Wednesday, November 4 th , 2020. The Company will h...
Part of stock picking is having to deal with the occasional portfolio loser. These can be spotted if one’s long-term thesis has not played out the way you were expecting in terms of actual fundamental results. I’ve written about Inogen ( INGN ) in the past and my original thesis ...
Inogen Inc (INGN) Q2 2020 Results Conference Call August 03, 2020 04:30 PM ET Company Participants Matthew Basco - Investor Relations Scott Wilkinson - President and Chief Executive Officer Alison Bauerlein - Chief Financial Officer Conference Call Participants Danielle Ant...
Inogen (NASDAQ: INGN ) : Q2 GAAP EPS of $0.12 beats by $0.20 . More news on: Inogen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
– Q2 2020 Total Revenue of $71.7 million – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended June 30, 2020. Secon...
Inogen ( INGN ) has been quite an intriguing stock in recent years. The producer of innovative respiratory products saw its share price practically explode from $30 to $300 between 2016 and late 2018. Now, two years later, we are back to $30 as heightened expectations have not turned into re...
Investment Thesis Inogen (INGN) is my backdoor bet on travel resumption. The core business is a proxy for leisure travel since their business thrives when patients suffering from chronic obstructive pulmonary diseases (COPD) seek mobility. COPD patients buy portable oxygen concentrators (P...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2020 financial results after market close on Tuesday, August 4 th , 2020. The Company will host a corresponding...
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that in connection with Inogen’s succession planning activities, Scott Wilkinson, the Company’s Chief Executive Officer and Preside...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...